The metabolic syndrome in polycystic ovary syndrome

Clin Obstet Gynecol. 2007 Mar;50(1):205-25. doi: 10.1097/GRF.0b013e31802f3547.


Approximately one-third to one-half of all women and adolescent girls with polycystic ovary syndrome (PCOS) has the metabolic syndrome, associated with increased risk for cardiovascular disease and type 2 diabetes. Evidence suggests that insulin resistance is the likely link between PCOS and the metabolic syndrome. Early screening for impaired glucose tolerance, even in adolescents, is recommended. Lifestyle modification with increased physical activity and weight reduction remains first-line therapy. Insulin-sensitizing drugs may also ameliorate features of the metabolic syndrome in PCOS but long-term prospective studies are needed to determine the role of these drugs in the prevention of the metabolic syndrome.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Cardiovascular Diseases / complications
  • Diabetes Mellitus, Type 2
  • Evidence-Based Medicine
  • Female
  • Humans
  • Metabolic Syndrome / complications*
  • Metabolic Syndrome / therapy
  • Polycystic Ovary Syndrome / complications*
  • Polycystic Ovary Syndrome / diagnosis
  • Prevalence
  • Risk Factors